4 results match your criteria: "Nara Medical University School of Medicine Graduate School of Medicine[Affiliation]"
Int J Rheum Dis
October 2023
Department of Neurology, Nara Medical University School of Medicine Graduate School of Medicine, Nara, Japan.
BMC Neurol
October 2021
Department of Neurology, Nara Medical University School of Medicine Graduate School of Medicine, 840 Shijo-Cho, Kashihara, Nara, 634-8522, Japan.
Background: Hypereosinophilia (HE) is caused by various conditions, including solid and hematologic tumors. Nonetheless, there exist no reports on cerebral infarctions caused by HE associated with lung cancer metastasis to the bone marrow.
Case Presentation: We report a case of a 67-year-old man with multiple cerebral infarctions associated with HE.
J Neurointerv Surg
June 2022
Department of Neurosurgery, Nara Medical University School of Medicine Graduate School of Medicine, Kashihara, Nara, Japan.
Background: It is vital to identify a surrogate last-known-well time to perform proper endovascular thrombectomy in acute ischemic stroke; however, no established imaging biomarker can easily and quickly identify eligibility for endovascular thrombectomy and predict good clinical prognosis.
Objective: To investigate whether low relative diffusion-weighted imaging (DWI) signal intensity can be used as a predictor of good clinical outcome after endovascular thrombectomy in patients with acute ischemic stroke.
Methods: We retrospectively identified consecutive patients with acute ischemic stroke who were treated with endovascular thrombectomy within 24 hours of the last-known-well time and achieved successful recanalization (modified Thrombolysis in Cerebral Infarction score ≥2b).
J Neurointerv Surg
November 2021
Department of Neurosurgery, Nara Medical University School of Medicine Graduate School of Medicine, Kashihara, Nara, Japan.
Background: Platelet function tests have been increasingly adopted to measure patient responses to antiplatelet drugs, and to predict complications. However, no established optimal antiplatelet management for stent-assisted coil embolization (SAC) have been established. The purpose of the present study was to investigate the efficacy and feasibility of clopidogrel dose adjustment for active target P2Y12 reaction unit (PRU).
View Article and Find Full Text PDF